Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus oral antidepressant in elderly patients with treatment-resistant depression
2014-004588-19Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Esketamine + oral antidepressant with Placebo nasal spray + oral antidepressant (2 arms). Primary endpoint: Change from baseline in Montgomery-Asberg Depression Rating Scale total score. Started Jun 2015; status: completed.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2014-004588-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004588-19.